Literature DB >> 17292455

Advanced malignant rhabdoid tumor of the ovary effectively responding to chemotherapy: a case report and review of the literature.

Chiaki Banzai1, Tetsuro Yahata, Jun Sasahara, Katsunori Kashima, Kazuyuki Fujita, Ken Nishikura, Yoichi Ajioka, Teiichi Motoyama, Kenichi Tanaka.   

Abstract

BACKGROUND: Malignant rhabdoid tumors (MRTs) are highly malignant neoplasms that consist of both renal and extrarenal subtypes. Primary ovarian cases are extremely rare. We herein describe the third known case of ovarian origin, which effectively responded to combination chemotherapy with ifosfamide, epirubicin, and cisplatin (IEP chemotherapy). CASE: A 19-year-old woman was diagnosed to have stage IIIc primary MRT of the ovary following the resection of tumors. Two months after surgery, an 8 cm-sized pelvic mass and enlarged retroperitoneal lymphnodes were detected. The patient received intravenous tri-weekly IEP chemotherapy. After the second course of chemotherapy, she demonstrated a complete clinical response.
CONCLUSION: Although this type of tumor is quite aggressive and chemotherapy is generally not considered to be effective, IEP chemotherapy may be useful in the treatment of MRT of the ovary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292455     DOI: 10.1016/j.ygyno.2007.01.013

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Malignant rhabdoid tumour of the liver in the young adult: report of first two cases.

Authors:  Ettore Marzano; Emilie Lermite; Cinzia Nobili; Carlos Teyssedou; Philippe Bachellier; Jean-Pierre Arnaud; Patrick Pessaux
Journal:  HPB Surg       Date:  2009-09-10

2.  A G-CSF-secreting adrenal carcinoma with rhabdoid-like differentiation causing leukocytosis.

Authors:  Emil Lou; Jeremy Goodwin; David N Howell; John Hicks; L Brett Caram
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

3.  Primary rhabdoid tumor of the ovary: When large cells become small cells.

Authors:  Alex Rabinovich; Leora Witkowski; Ruthy Shaco-Levi; Mihai Meirovitz; Martin Hasselblatt; William D Foulkes
Journal:  Gynecol Oncol Rep       Date:  2015-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.